Login
Medtronic NYSE: MDT
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals
| Name | Medtronic |
| Ticker | MDT |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Medical Devices |
| Price | 116.75 |
| 52W Low/High | 72.92 / 121.30 |
| Market cap | 157 B |
| 1Y Total Return |
-0.17%
Below Average |
| 1Y Volatility |
41.18%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals
Details
| Ticker | MDT |
| Name | Medtronic |
| ISIN | IE00BTN1Y115 |
| CUSIP | G5960L103 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Medical Devices |
| Country | USA |
| Currency | U.S. Dollar |
| In Index(ices) |
|
Share as of 1/26/21
| Close Price | 116.75 |
| 52W Low/High | 72.92 / 121.30 |
| Market cap | 157 B |
| 1Y Total Return |
-0.17%
Below Average |
| 1Y Volatility |
41.18%
Low Risk |
| Beta | 1.39 |
| PE (trailing) |
44.73
Above Average |
| 12M Dividends | 2.24 |
| Last Dividend Date | 12/21/20 |
| Dividend Yield | 1.92% |
Fin. Strength
| Net Profit Margin | 12.7% |
| Cash from Op. / Cur. Liabilities | 0.50 |
| Diluted Earnings / Share | 2.61 |
| ROE | 7.0% |
| ROIC | 5.6% |
| Price / Revenue | 5.7 |
| Price / Book | 3.1 |
| Price / CF | 26.3 |
| Current Ratio | 2.2 |
| Cur.Liabilities / Tot.Liabilities | 0.3 |
| Financial Leverage | 0.60 |
| in Mils USD |
rolling-year up to September
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
27,868
|
30,891
|
30,378
|
29,639
|
29,012
|
25,954
|
|
| Gross Profit |
17,994
|
21,383
|
21,379
|
20,457
|
19,921
|
17,254
|
|
| R&D |
2,401
|
2,345
|
2,326
|
2,188
|
2,231
|
2,004
|
|
| EBITDA |
6,521
|
9,306
|
8,995
|
9,399
|
8,308
|
6,359
|
|
| Operating Income |
3,558
|
6,324
|
6,144
|
6,107
|
5,482
|
4,079
|
|
| Net Income exc. Extra |
3,537
|
4,669
|
2,261
|
5,017
|
4,242
|
2,316
|
|
| per Share | |||||||
| Diluted avg Shares |
1,352
|
1,351
|
1,361
|
1,366
|
1,393
|
1,429
|
|
| EPS exc. Extra |
2.61
|
3.46
|
1.65
|
3.65
|
3.01
|
1.64
|
|
| Dividend |
2.24
|
2.08
|
1.92
|
1.78
|
1.62
|
1.37
|
|
| Div. Yield (an.) |
2.23%
|
1.97%
|
2.14%
|
2.19%
|
1.98%
|
1.85%
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
95,886
|
91,053
|
88,150
|
94,458
|
98,406
|
104,945
|
|
| Cash, Eq & Invt ShortTerm |
14,277
|
10,398
|
10,133
|
13,526
|
11,257
|
17,229
|
|
| Total Current Assets |
26,036
|
22,653
|
21,653
|
25,162
|
22,526
|
28,723
|
|
| Total Non-Current Assets |
69,850
|
68,400
|
66,497
|
69,296
|
75,880
|
76,222
|
|
| Intangibles |
59,624
|
59,727
|
59,424
|
61,702
|
68,446
|
69,005
|
|
| Total Liabilities |
45,570
|
40,334
|
38,436
|
42,880
|
48,113
|
52,676
|
|
| Total Current Liabilities |
12,071
|
8,170
|
8,463
|
10,496
|
9,601
|
8,126
|
|
| Long Term Debt |
33,499
|
32,164
|
29,973
|
32,384
|
38,512
|
44,550
|
|
| Shareholder equity |
50,164
|
50,578
|
49,607
|
51,469
|
50,186
|
52,269
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
5,996
|
7,519
|
5,905
|
5,502
|
6,145
|
5,774
|
|
| Depreciation |
2,675
|
2,670
|
2,647
|
2,762
|
2,892
|
2,280
|
|
| Cash from Investing |
-3,448
|
-3,305
|
497
|
4,911
|
3,962
|
-17,979
|
|
| Capex |
1,244
|
1,221
|
1,041
|
1,180
|
1,198
|
807
|
|
| Cash from Financing |
-192
|
-4,143
|
-7,980
|
-7,909
|
-9,669
|
13,551
|
|
| Stock Issued |
-83
|
-1,168
|
-1,357
|
-2,240
|
-3,676
|
-1,160
|
|
| Debt (LT) Issued |
2,993
|
-135
|
-3,983
|
-3,185
|
-3,805
|
16,636
|
|
| Free Cash Flow |
10,621
|
6,744
|
2,068
|
8,508
|
6,718
|
818
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
12.7%
|
15.1%
|
7.4%
|
16.9%
|
14.6%
|
8.9%
|
|
| NCFO / Op.Income |
168.5%
|
118.9%
|
96.1%
|
90.1%
|
112.1%
|
141.6%
|
|
| Current Ratio |
2.2
|
2.8
|
2.6
|
2.4
|
2.3
|
3.5
|
|
| Financial Leverage D/E |
0.60
|
0.51
|
0.50
|
0.56
|
0.65
|
0.69
|
|
| Return on Capital Avg |
5.6%
|
8.2%
|
3.6%
|
7.5%
|
5.5%
|
4.5%
|
|
| Return on Shareholder Equity |
7.0%
|
9.3%
|
4.5%
|
9.9%
|
8.3%
|
6.5%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available